Heart mystery: do Nerve-Targeting drugs also protect the heart?
NCT ID NCT05873868
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 21 times
Summary
This study looks at 20 adults with hereditary ATTR amyloidosis who have both nerve and early heart problems. They are being treated with patisiran or vutrisiran, drugs known to slow nerve damage. Researchers want to see if these drugs also help the heart by using MRI scans and heart symptom questionnaires over 24 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN AMYLOIDOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
APHP Henri Mondor
Créteil, France
-
CHU Bordeaux Haut-Levêque
Bordeaux, France
-
CHU Grenoble Alpes
Grenoble, France
-
CHU Nancy Institut Louis Mathieu
Nancy, France
-
CHU Rangueil Toulouse
Toulouse, France
Conditions
Explore the condition pages connected to this study.